Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Tegoprubart by Eledon Pharmaceuticals for Kidney Transplant Rejection: Likelihood of Approval
Tegoprubart is under clinical development by Eledon Pharmaceuticals and currently in Phase II for Kidney Transplant Rejection. According to GlobalData,...